Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises FAM AB on the acquisition of Sandvik Process Systems
Mandate

Vinge advises FAM AB on the acquisition of Sandvik Process Systems

June 02, 2017 M&A

Vinge advises FAM AB on the acquisition of Sandvik Process Systems (”SPS”) from Sandvik AB at a price of approximately SEK 5 bn.

Sandvik Process Systems delivers advanced industrial process solutions based on high-end steel belts, steel belt based equipment and process solutions within adjacent technologies. The transaction is subject to competition clearance.

Vinge’s team includes responsible partner Jonas Johansson and counsel Matthias Pannier together with partners Eva Fredrikson and Assur Badur, counsel Johan Cederblad and associates Karl Klackenberg, Mathilda Persson, Johanna Wiberg, Sara Strandberg, Sofia Ekdahl, Grant McKelvey, Johan Wahlbom, Isabell Nielsen, Rebecka Weitzberg, Karin Virding, Linn Adelwald, Carolina Sandell, Jasmin Draszka-Ali, Hedvig Ekdahl, Olof Johannesson, Siri Dunér as well as VDR specialist Anna Hellohf.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025